Crescent BiopharmaCBIO

13F holders, Q4 2025 (December 31)
56holders +15
20new positions
6sold out
3famous investors
$11.85avg. 13F price*

At the end of Q4 2025, 56 institutions reported holding Crescent Biopharma Inc. (CBIO) in their 13F filings, up 15 from Q3 2025. 20 opened new positions and 6 sold out. The largest holders were FMR LLC ($49.0M), BVF Inc. ($32.6M) and Fairmount Funds Management LLC ($32.6M). 3 famous investors held it, including Steve Cohen (0.0% of Point72 Asset Management's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).

Company
Crescent Biopharma Inc.
CUSIP
G2545C104
Latest filing quarter
Q2 2026

History

Number of 13F holders

020406080 Q2 2025: 30Q2 2025Q3 2025: 41Q3 2025Q4 2025: 56Q4 2025Q1 2026: 60Q1 2026Q2 2026: 80Q2 2026

Total Exit/New Position Q3 2025 → Q4 2025

InstitutionsTotal Value
New Positions20$79.8M
Exits6$13.9M

All 13F filers, Q3 2025 → Q4 2025: 13,441,234 shares bought and 1,391,117 shares sold, net +12,050,117 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 56 holders

FMR LLC 0.00% Add +192.2% 4,133,514 $49.0M
BVF Inc. 1.10% Add +98.1% 2,748,763 $32.6M
Fairmount Funds Management LLC 2.48% Add +98.0% 2,747,866 $32.6M
Venrock Adviser, LLC 1.25% Add +53.7% 2,133,576 $25.3M
FCPM III Services B.V. 2.61% New 1,677,852 $19.9M
Vestal Point Capital, LP 0.65% New 1,500,000 $17.8M
Opaleye Management Inc. 1.84% New 1,178,300 $14.0M
Tang Capital Management LLC 0.51% Add +28.3% 872,398 $10.3M
ADAR1 Capital Management, LLC 0.54% New 606,000 $7.2M
Logos Global Management LP 0.47% No change 600,000 $7.1M
Vanguard Group Inc. 0.00% Reduce -15.3% 557,506 $6.6M
Boxer Capital Management, LLC 1.18% No change 453,686 $5.4M
Deep Track Capital, LP 0.12% No change 453,686 $5.4M
Perceptive Advisors LLC 0.10% No change 453,686 $5.4M
NEXTBio Capital Management LP 2.59% — 372,856 $4.4M
RTW Investments, LP 0.04% New 372,856 $4.4M
T. Rowe Price Associates Inc. 0.00% Reduce -11.8% 338,125 $4.0M
Driehaus Capital Management LLC 0.02% No change 302,457 $3.6M
Point72 Asset Management 0.01% New 300,000 $3.6M
Heights Capital Management, Inc. 1.20% New 264,000 $3.1M
Alyeska Investment Group, L.P. 0.01% New 264,000 $3.1M
Wellington Management Group LLP 0.00% Add +710.3% 143,412 $1.6M
Two Sigma Investments, LP 0.00% Add +342.2% 125,224 $1.5M
Balyasny Asset Management L.P. 0.00% New 111,715 $1.3M
BlackRock, Inc. 0.00% Add +0.1% 109,230 $1.3M
Geode Capital Management, LLC 0.00% Add +31.7% 91,079 $1.1M
Stonepine Capital Management, LLC 0.82% New 87,682 $1.0M
Blackstone Inc. 0.00% No change 75,614 $897K
Woodline Partners LP 0.00% New 74,000 $878K
Burkehill Global Management, LP 0.06% New 74,000 $844K
Jefferies Financial Group Inc. 0.01% Reduce -37.5% 64,244 $762K
Millennium Management 0.00% New 61,882 $734K
Susquehanna International Group, LLP 0.00% New 57,048 $677K
Renaissance Technologies 0.00% Add +73.6% 46,700 $554K
Two Sigma Advisers, LP 0.00% New 32,500 $385K
Morgan Stanley 0.00% Add +18880.0% 27,521 $326K
State Street Corp. 0.00% Add +40.8% 26,217 $311K
Goldman Sachs Group Inc. 0.00% Reduce -31.7% 25,245 $299K
Moore Capital Management, LP 0.01% New 25,000 $297K
Manufacturers Life Insurance Company, The 0.00% Reduce -0.1% 24,903 $289K
JPMorgan Chase & Co. 0.00% Add +137188.2% 23,339 $277K
Jane Street Group, LLC 0.00% New 22,965 $272K
Marshall Wace, LLP 0.00% Reduce -50.0% 21,826 $259K
Northern Trust Corp. 0.00% Add +2.5% 17,229 $204K
HRT Financial LP 0.00% New 13,083 $155K
OMERS ADMINISTRATION Corp 0.00% New 11,600 $138K
UBS Group AG 0.00% Reduce -43.7% 7,125 $85K
Bank of America Corp. 0.00% Add +44.3% 5,573 $66K
BNP Paribas Financial Markets 0.00% Add +89525.0% 3,585 $43K
Citigroup Inc. 0.00% Reduce -21.9% 623 $7K
Tower Research Capital LLC (TRC) 0.00% Add +104.5% 409 $5K
SBI Securities Co., Ltd. 0.00% No change 68 $806
Osaic Holdings, Inc. 0.00% No change 26 $308
Group One Trading LLC 0.00% Reduce -95.1% 4 $47
Royal Bank of Canada 0.00% No change 20 $0
Avion Wealth 0.00% New 40 $0

"% of holder's portfolio" is CBIO's weight in each manager's 13F, not the share of Crescent Biopharma Inc. the manager owns.